With money for basic and clinical research squeezed,some health researchers – including the UK team behind a dementia drug – are trying crowdfundingTests on a drug with the potential to conclude Alzheimer’s in its tracks are being funded by raffles, pensioners’ donations and a sponsored walk – because the research team cannot find money for pre-clinical safety tests any other way.
The team of researchers led by Dr David Allsop at Lancaster University’s division of biomedicine and life sciences is running a crowdfunding campaign, and Defying Dementia,to carry out the essential preparatory testing on their drug in the belief they may be looking at a cure for the progressive brain disease. So far they have raised £52000 towards their target of £165000.
Continue reading...
Source: theguardian.com